Rapid Pathogen Screening Overview

  • Founded
  • 2004
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 72
Employees
  • Latest Deal Type
  • M&A

Rapid Pathogen Screening General Information

Description

Developer of point-of-care (POC) diagnostic tests intended to improve the health and well-being of patients around the world. The company's diagnostic tests focus on designing, developing and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bioterrorism and chemical nerve agent blood toxins, allowing healthcare providers to more accurately diagnose diseases, provide appropriate and timely treatment and reduce healthcare costs associated with the spread of disease and unnecessary treatment methods.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 7227 Delainey Court
  • Sarasota, FL 34240
  • United States
+1 (941) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rapid Pathogen Screening Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 29-May-2019 000.00 Completed Generating Revenue
6. Debt - General 13-Oct-2014 0000 000.00 Completed Generating Revenue
5. Mezzanine 22-Jul-2013 00.000 000.00 Completed Generating Revenue
4. Later Stage VC 19-Jul-2013 00.000 000.00 Completed Generating Revenue
3. Angel (individual) 20-Oct-2012 00.000 000.00 Completed Generating Revenue
2. Undetermined 29-Jan-2010 $15M $18.4M Completed Generating Revenue
1. Angel (individual) 05-Feb-2007 $3.39M $3.39M Completed Startup
To view Rapid Pathogen Screening’s complete valuation and funding history, request access »

Rapid Pathogen Screening Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rapid Pathogen Screening Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mallitz Investment Group Lender/Debt Provider Minority 000 0000 000000 0
OrbiMed PE/Buyout Minority 000 0000 000000 0
To view Rapid Pathogen Screening’s complete investors history, request access »